Skip to main content
Home
TERUMO GLOBAL

Select Region

Show — Select Region Hide — Select Region
    • Regions/Countries
        • Japan
        • United States
            • Terumo Interventional Systems
            • Terumo Cardiovascular
            • MicroVention (Neurovascular)
            • Terumo Blood and Cell Technologies
            • Terumo Aortic
            • Terumo Medical Products
            • Terumo Medical Corp
            • Terumo Health Outcomes
        • Canada
        • Europe
        • Latin America
            • Mexico
            • Brazil
            • Colombia
            • Chile and Argentina
            • Latin America
        • Asia Pacific
        • Australia
        • Korea
        • Vietnam
        • China
        • India
    • Global Business website
        • Terumo Cardiovascular
        • Terumo Aortic
        • MicroVention (Neurovascular)
        • Terumo Blood and Cell Technologies
        • Pharmaceutical Solutions
  • About Terumo
    About Terumo
      • Dear Stakeholders
      • Terumo Group Identity
      • Terumo Group Code of Conduct
      • Corporate Profile
      • Corporate Governance
      • Compliance
      • Procurement Activity
      • Regulations and Standards
      • Directors and Executive Officers
      • History
      • Our Stories
      • Terumo's Response to COVID-19
  • Business Overview
    Business Overview
      • TIS Division (Terumo Interventional Systems)
      • Neurovascular Division (MicroVention)
      • Cardiovascular Division (Terumo Cardiovascular)/ HeartSheet Division
      • Vascular Graft Division (Terumo Aortic)
      • Hospital Care Solutions Division / Life Care Solutions Division
      • Pharmaceutical Solutions Division
      • Terumo Blood and Cell Technologies Company (Terumo Blood and Cell Technologies)
  • Sustainability
    Sustainability
      • Sustainability News
      • Message from Top Management
      • Sustainability at the Terumo Group
      • Resolving Healthcare Challenges
      • Creating a Diverse and Inclusive Workplace
      • Reducing Environmental Footprint
      • Serving Our Communities
      • Report Library
      • GRI Standards Index
  • Technology
    Technology
      • Basic Information
          • Basic Information Top
          • Research and Development
          • Production and Supply
          • Intellectual Property
          • Terumo Fellows
      • Stories - Our Technologies
  • Investors
    Investors
      • Management Policy
          • Management Policy
          • Top Management Message
          • Business Risks
          • Disclaimer
          • IR Policy
      • Financial Highlights
      • IR Library
          • IR Library
          • Financial Statements
          • Presentations
          • Consolidated Financial Statements
          • Terumo Reports
      • IR Events
      • Shareholders & Stock
          • Shareholders Meeting
          • Stock Information
          • Shareholder Return
          • Credit Ratings and Corporate Bond
          • Analyst Coverage
          • Articles of Incorporation
          • Site Quote
      • IR Inquiries
  • News
    News
      • May 25, 2022
        Corporate
        Terumo Blood and Cell Technologies Inaugurates Second Manufacturing Facility in Colorado
      • May 17, 2022
        Corporate
        Terumo Pharmaceutical Solutions Offers Pre-Fillable Syringe Solutions for Demanding Low Dose Applications Such as Ophthalmic
      • May 16, 2022
        Corporate
        Terumo Announces Change in Indication for Dexcom G6 CGM System in Japan

        Adjunctive use of Blood Glucose Meter Principally Not Required

      • 2022
      • 2021
      • 2020
      • 2019
      • 2018
      • 2017
      • 2016
      • 2015
      • 2014
      • 2013
      • 2012
    • Global Network
      Global Network
        • Japan
        • North America
        • South America
        • Europe, Middle East and Africa
        • Greater China
        • Asia and Pacific

    Breadcrumb

    1. Home
    2. Technology
    3. Basic Information

    Basic Information

    Move to topTop
    mainvisual_EN
    mainvisual_sp_EN

    Basic Information

    Basic thinking and organization

    Introduces our basic thinking in areas including R&D and production, our organizational structure, our intellectual property, the Terumo Fellow program, and more.

    • Research and Development

      Introduces the basic R&D thinking and global R&D organization of the Terumo Group.

    • Production and Supply

      Introduces the production technology that sustains Terumo monozukuri, and the Terumo global production system.

    • Intellectual Property

      Introduces the basic Terumo thinking regarding intellectual property, and patent-related information.

    • Terumo Fellows

      Introduces the Terumo Fellow Program, which recognizes Terumo Associates who have outstanding expertise and experience in technology, research, and clinical development, and who make notable achievements in contributing to global healthcare.

    Footer Menu

    Show — Footer Menu Hide — Footer Menu
      • About Terumo
          • About Terumo
          • Dear Stakeholders
          • Terumo Group Identity
          • Terumo Group Code of Conduct
          • Corporate Profile
          • Corporate Governance
          • Compliance
          • Procurement Activity
          • Regulations and Standards
          • Directors and Executive Officers
          • History
          • Our Stories
          • Terumo's Response to COVID-19
      • Business Overview
          • Business Overview
          • TIS Division (Terumo Interventional Systems)
          • Neurovascular Division (MicroVention)
          • Cardiovascular Division (Terumo Cardiovascular)/ HeartSheet Division
          • Vascular Graft Division (Terumo Aortic)
          • Hospital Care Solutions Division / Life Care Solutions Division
          • Pharmaceutical Solutions Division
          • Terumo Blood and Cell Technologies Company (Terumo Blood and Cell Technologies)
      • Sustainability
          • Sustainability Overview
          • Sustainability News
          • Message from Top Management
          • Sustainability at the Terumo Group
          • Resolving Healthcare Challenges
          • Creating a Diverse and Inclusive Workplace
          • Reducing Environmental Footprint
          • Serving Our Communities
          • Report Library
          • GRI Standards Index
      • Technology
          • Technology Overview
          • Basic Information
              • Research and Development
              • Production and Supply
              • Intellectual Property
              • Terumo Fellows
          • Stories - Our Technologies
      • Investors
          • Investors
          • Management Policy
              • Top Management Message
              • Business Risks
              • Disclaimer
              • IR Policy
          • Financial Highlights
          • IR Library
              • Financial Statements
              • Presentations
              • Consolidated Financial Statements
              • Terumo Reports
          • IR Events
          • Shareholders & Stock
              • Shareholders Meeting
              • Stock Information
              • Shareholder Return
              • Credit Ratings and Corporate Bond
              • Analyst Coverage
              • Articles of Incorporation
              • Site Quote
          • IR Inquiries
      • News
          • News
          • Press Inquiries
      • Global Network
          • Japan
          • North America
          • South America
          • Europe, Middle East and Africa
          • Greater China
          • Asia and Pacific
    • About Terumo
    • Business Overview
    • Sustainability
    • Technology
    • Investors
    • News
    • Global Network

    Footer

    Show — Footer Hide — Footer
    • Terms and Conditions of Use
    • Privacy Policy
    • Cookie Policy
    • Cookie Settings
    • Social Media Policy
    • Site Map

    Copyright © 2022 Terumo Corporation, All Rights Reserved.